Introduction
============

Pancreatic cancer is the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related mortality worldwide ([@b1-ol-0-0-11181]). Because of its characterizations of aggressive and early dissemination, the overall 5-year survival rate of pancreatic cancer patients is a dismal 3--5%, which increases to 15--25% among those who undergo curative resection ([@b2-ol-0-0-11181],[@b3-ol-0-0-11181]). However, the mortality rate remains high and has not shown any obvious improvement in the past few decades. A better understanding of the underlying molecular mechanisms of this cancer might contribute to demarcate the patients into different prognostic groups, as well as identify novel markers associated with prognosis.

Hypoxia is one of the common features of human cancers, and manifested histologically by necrosis and peritumoral fibrosis (PF) ([@b4-ol-0-0-11181]--[@b6-ol-0-0-11181]). Tumor necrosis has been identified as a marker of poor prognosis in renal, breast, lung, pancreatic and colorectal cancers ([@b7-ol-0-0-11181]--[@b10-ol-0-0-11181]), whereas PF affects the outcome and prognosis of inflammatory and hematopoietic disorders ([@b11-ol-0-0-11181],[@b12-ol-0-0-11181]). No study so far has analyzed the formation of PF and its potential relationship to the clinicopathological parameters and prognosis of pancreatic head cancer (PHC). The present study evaluated the clinical significance and prognostic value of PF in PHC patients after resection.

Patients and methods
====================

### Patients and tumor samples

Total of 143 samples from patients with PHC resection between January 2007 and December 2011 at the Department of Hepatobiliary Surgery, Yi Ji Shan Hospital of Wannan Medical College were included in the present study. All patients with PHC received routine preoperative work-up including a contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI). The contraindications for curative resection included metastases, complete occlusions of the superior-mesenteric/portal vein or arterial infiltration (\>180° circumference), except tumor contact to the portal vein alone. All the patients with PHC underwent the Kausch-Whipple procedure and standard lymphadenectomy along the right side of the superior mesenteric artery, the hepatoduodenal ligament, and the celiac trunk/upper pancreatic margin. PHC was confirmed histopathologically and classified according to the criteria of World Health Organization and the American Joint Committee on Cancer (AJCC) ([@b13-ol-0-0-11181],[@b14-ol-0-0-11181]). Patients who underwent preoperative chemoradiation were excluded since it affects the ratio of fibrosis to cancer cells ([@b15-ol-0-0-11181]).

The study was approved by the Ethics Committee of The First Affiliated Hospital of Wannan Medical College (Wuhu, China). Patients who participated in this research had complete clinical data. Signed informed consents were obtained from the patients and/or the guardians.

Formalin-fixed and paraffin-embedded (FFPE) tumor tissue blocks were retrieved from the database of the Department of Pathology, Yijishan Hospital of Wannan Medical College, sectioned, and stained with hematoxylin and eosin (H&E) for histological analysis of the primary tumor stage and nodal status. The clinicopathological characteristics of the patients with pancreatic head cancer are summarized in [Table I](#tI-ol-0-0-11181){ref-type="table"}. The patients were followed up after the operation by telephone conversation and/or out-patient clinic interviews.

### Classification of PF

The tumor specimens were classified into 3 categories according to the degree of PF: negative (\<10% fibrotic change), moderate (11--30%) and severe (\>30%).

### Statistical analysis

All statistical analyses were performed using the R3.1.3 program (<http://www.R-project.org>). Pearson\'s Chi-square test and Fisher exact probability test were performed to analyze the correlation between different parameters. Univariate Kaplan-Meier analysis was performed to assess the prognostic factors for survival, as well as compared using the two-sided log-rank test. The Cox proportional hazard model (forward selection strategy using a likelihood ratio statistic; inclusion P=0.05) was performed by multivariate survival analysis, including hazard ratios and their 95% confidence interval. P-values \<0.05 were considered statistically significant.

Results
=======

### Clinicopathological characteristics of the patients

The clinicopathological features of patients with PHC who underwent pancreatic tumor resection are summarized in [Table I](#tI-ol-0-0-11181){ref-type="table"}. The median age of patients was 64 years (range 32--85 years). PF was not significantly correlated with any of the clinicopathological factors.

### Univariate survival analysis

No patient died during the postoperative course. The median follow-up duration of the entire cohort was 28.7 months (range 5.3--60 months), and the median survival was 1.95 years. The cumulative 3- and 5-year survival rates were 31 and 19%, respectively. Univariate analysis ([Table II](#tII-ol-0-0-11181){ref-type="table"}) showed that vein resection, resection margin, grading, nodal status, preoperative values of CA19-9 and PF were significantly associated with survival. Patients with PF had significantly worse survival compared to those without (HR 3.079; P\<0.001) ([Fig. 1](#f1-ol-0-0-11181){ref-type="fig"}). The overall survival (OS) of patients with mild and severe PF is shown in [Fig. 2](#f2-ol-0-0-11181){ref-type="fig"} (P=0.02).

### Multivariate survival analysis

Multivariate analysis ([Table III](#tIII-ol-0-0-11181){ref-type="table"}) indicated that resection margin, vein resection, grading, preoperative values of CA19-9, nodal status and PF were all independent predictive factors of survival. The survival of patients with PF was significantly worse than those without (HR 1.392; P=0.027).

Discussion
==========

Correlation between the presence of PF and various clinicopathological parameters were evaluated in 143 pancreatic head cancer patients who underwent tumor resection. This is the first study to show the association between PF and poor post-resection overall survival in pancreatic cancer patients, and identify it as an independent negative prognostic factor ([Fig. 3](#f3-ol-0-0-11181){ref-type="fig"}).

Scarce data is available on the association between PF and the clinico-pathological characteristics of pancreatic cancers. A recent study indicated the diagnostic importance of histological PF in PHCs ([@b16-ol-0-0-11181]). Consistent with this, we found that the presence of PF, as well as the severity of necrosis, was associated with significantly decreased OS. In addition, PF was also identified as independent prognostic factor of post-resection outcome. Based on our results, we hypothesize a diagnostic value of PF in evaluating the post-resection outcome in PHC patients. A rational clinical translation of these results suggests standardized utilization of PF as a prognostic tool in the scope of pathological evaluation of resected specimens from patients suffering from pancreatic head cancer.

The cause of fibrosis in PHC and the mechanisms underlying the poor clinical outcome in patients with PF remain largely unknown. One hypothesis is that inflammation, which has been recently described as the seventh hallmark of cancer ([@b17-ol-0-0-11181],[@b18-ol-0-0-11181]), likely plays a role in the formation of fibrotic masses as well. Furthermore, there is evidence indicating that pancreatic stellate cells trigger fibrosis through various stromal interactions and allow wound healing, thereby promoting cancer cell invasion and dissemination ([@b19-ol-0-0-11181]--[@b21-ol-0-0-11181]). Despite recent advances in our understanding of the genetic and cellular basis of pancreatic head cancer progression, its diagnostic and prognostic evaluation is still mostly dependent on histopathological assessment. The histopathological parameters such as tumor grading and PF are easy to evaluate, and can allow individualized risk assessment and identify patients at high risk of poor outcome.

There are several limitations to our study, including those inherent to retrospective analyses. In addition, the surgical resection was performed by multiple surgeons, and reliable histological evaluation was only possible with the resected tumor specimens. This can be circumvented in future with high-resolution magnetic resonance imaging (MRI), which can allow non-invasive *in vivo* visualization at a 3D spatial resolution of up to 50 µm ([@b22-ol-0-0-11181]--[@b24-ol-0-0-11181]). Despite these limitations, our data suggest that PF is a simple diagnostic tool that can evaluate patients\' outcome after resection of PHC.

In conclusion, PF is an independent prognostic factor of PHC and predictive of poor survival after resection. This indicates its potential role in pancreatic cancer progression as well as its diagnostic utility. Future prospective trials are needed to assess the value of PF as a criterion for adjuvant treatment.
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###### 

Relationship between clinicopathological characteristics and presence of peritumoral fibrosis.

                                           Peritumoral fibrosis        
  ---------------------------------- ----- ---------------------- ---- -------
  Age (years)                                                          0.404
    \<70                             104   64                     40   
    ≥70                              39    21                     18   
  Sex                                                                  0.663
    Female                           61    43                     18   
    Male                             82    55                     27   
  Intraoperative blood transfusion                                     0.918
    Yes                              42    30                     12   
    No                               101   73                     28   
  Vein resection                                                       0.820
    Yes                              25    14                     11   
    No                               118   69                     49   
  Grading                                                              0.814
    G1/2                             114   72                     42   
    G3/4                             29    19                     10   
  T stage                                                              0.067
    T1/2                             21    14                     7    
    T3/4                             122   102                    20   
  Resection margin                                                     0.140
    Negative                         105   72                     33   
    Positive                         38    21                     17   
  Nodal status                                                         0.678
    Negative                         82    51                     31   
    Positive                         61    40                     21   
  Preoperative CA19-9 (U/ml)                                           0.842
    \<37                             21    14                     7    
    ≥37                              122   84                     38   
  No. of examined nodes                                                0.327
    \<12                             52    23                     29   
    ≥12                              91    48                     43   
  Complications                                                        0.339
    Yes                              70    28                     42   
    No                               73    35                     38   

###### 

Univariate survival analysis after resection of pancreatic head cancer.

  Characteristics                    No. of patients   HR      95% CI         P-value
  ---------------------------------- ----------------- ------- -------------- -------------
  Age (years)                                                                 
    \<70                             104               0.923   0.611--1.394   0.704
    ≥70                              39                1                      
  Sex                                                                         
    Female                           61                1.051   0.746--1.480   0.777
    Male                             82                1                      
  Intraoperative blood transfusion                                            
    Yes                              42                1.182   0.790--1.767   0.790
    No                               101               1                      
  Vein resection                                                              
    Yes                              25                1.646   1.048--2.588   **0.031**
    No                               118               1                      
  Grading                                                                     
    G1/2                             114               1                      
    G3/4                             29                1.843   1.135--2.993   **0.013**
  T stage                                                                     
    T1/2                             21                0.683   0.414--1.128   0.136
    T3/4                             122               1                      
  Resection margin                                                            
    Negative                         105               1                      
    Positive                         38                1.542   1.022--2.324   **0.039**
  Nodal status                                                                
    Negative                         82                1                      
    Positive                         61                1.790   1.257--2.556   **0.001**
  Preoperative CA19-9 (U/ml)                                                  
    \<37                             21                1.783   1.070--2.972   **0.026**
    ≥37                              122               1                      
  No. of examined nodes                                                       
    \<12                             52                0.883   0.575--1.178   0.288
    ≥12                              91                1                      
  Peritumoral fibrosis                                                        
    Presence                         85                3.079   1.975 −4.844   **\<0.001**
    Absence                          58                1                      
  Complications                                                               
    Yes                              70                0.885   0.624--1.255   0.493
    No                               73                1                      

P-value in bold print indicates statistical significance.

###### 

Multivariate survival analysis after resection of pancreatic head cancer.

  Characteristics              No. of patients   HR      95% CI         P-value
  ---------------------------- ----------------- ------- -------------- -------------
  Vein resection                                                        
    Yes                        25                2.251   1.348--3.758   **0.002**
    No                         118               1                      
  Grading                                                               
    G1/2                       114               1                      
    G3/4                       29                1.856   1.145--3.009   **0.012**
  Resection margin                                                      
    Negative                   105               1                      
    Positive                   38                1.977   1.212--3.225   **0.006**
  Nodal status                                                          
    Negative                   82                1                      
    Positive                   61                2.973   1.947--4.540   **\<0.001**
  Preoperative CA19-9 (U/ml)                                            
    \<37                       21                2.398   1.166--4.926   **0.017**
    ≥37                        122               1                      
  Peritumoral fibrosis                                                  
    Presence                   85                1.392   1.038--1.869   **0.027**
    Absence                    58                1                      

P-value in bold print indicates statistical significance.
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